<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Infection control measures for prevention of seasonal influenza</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Infection control measures for prevention of seasonal influenza</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Infection control measures for prevention of seasonal influenza</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Tara N Palmore, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Martin S Hirsch, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 26, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>In order to optimally prevent or control influenza outbreaks, it is important to identify cases early and implement multiple infection control measures as soon as possible [<a href="#rid1">1</a>]. Recommendations regarding infection control measures for seasonal influenza infection in health care settings have been provided by the United States Centers for Disease Control and Prevention and will be reviewed here [<a href="#rid2">2</a>]. </p><p>Health care settings include acute care hospitals, long-term care facilities (eg, nursing homes, skilled nursing facilities), physicians' offices, urgent care centers, outpatient clinics, and home health care [<a href="#rid2">2</a>].</p><p>Other prevention strategies for seasonal and avian influenza virus infections are discussed separately. (See  <a class="medical medical_review" href="/d/html/5985.html" rel="external">"Seasonal influenza in children: Management"</a> and  <a class="medical medical_review" href="/d/html/7017.html" rel="external">"Seasonal influenza in adults: Role of antiviral prophylaxis for prevention"</a> and  <a class="medical medical_review" href="/d/html/132409.html" rel="external">"Seasonal influenza in children: Prevention with antiviral drugs"</a> and  <a class="medical medical_review" href="/d/html/138869.html" rel="external">"Avian influenza: Treatment and prevention"</a>.)</p><p class="headingAnchor" id="H90592385"><span class="h1">TRANSMISSION</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Modes of transmission</strong> – Influenza virus spreads primarily via person-to-person respiratory transmission, which occurs via close-range contact (ie, within approximately six feet) via large droplets (≥100 microns) and as well as aerosols (&lt;100 microns) [<a href="#rid3">3-5</a>]. When an infected person coughs, sneezes, or talks, virus within respiratory secretions can infect another person if it is inhaled or if it contacts the mucous membranes. </p><p></p><p class="bulletIndent1">Influenza virus can also be transmitted longer distances through the airborne route (through inhalation of small particle aerosols that remain suspended in the air over time and distance). The extent of this mode of transmission is uncertain [<a href="#rid6">6-8</a>]. </p><p></p><p class="bulletIndent1">Influenza virus transmission can also occur if a person touches a surface contaminated by respiratory secretions and then touches their eyes, nose, or mouth [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Incubation period</strong> – The typical incubation period is one to four days (average two days) [<a href="#rid10">10,11</a>]. The time between onset of illness among household contacts (known as the serial interval) is three to four days [<a href="#rid12">12</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Viral shedding</strong> – In immunocompetent hosts, influenza viral shedding occurs at or just before the onset of symptoms (0 to 24 hours), peaks at 24 to 48 hours of illness, and then rapidly declines, with little or no detectable virus after 5 to 10 days [<a href="#rid13">13-16</a>]. Longer periods of shedding (weeks to months) can occur in adults ≥65 years, individuals with chronic illnesses, persons with obesity and immunocompromised patients [<a href="#rid17">17-20</a>]. </p><p></p><p class="headingAnchor" id="H1274748920"><span class="h1">INFECTION PREVENTION IN THE HEALTH CARE SETTING</span></p><p class="headingAnchor" id="H3"><span class="h2">Overview</span><span class="headingEndMark"> — </span>The United States Centers for Disease Control and Prevention (CDC) has suggested that the following measures be undertaken to prevent the spread of seasonal influenza viruses in health care settings [<a href="#rid2">2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Promote and administer the seasonal influenza vaccine to health care personnel (HCP), emergency medical services personnel, and patients, annually. This is the most important measure to prevent seasonal influenza infections. (See  <a class="medical medical_review" href="/d/html/7007.html" rel="external">"Seasonal influenza vaccination in adults"</a> and  <a class="medical medical_review" href="/d/html/3889.html" rel="external">"Immunizations for health care providers", section on 'Influenza vaccine'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Take steps to minimize potential exposures. (See <a class="local">'General steps to minimize exposures'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Monitor and manage ill HCP. (See <a class="local">'Managing health care personnel'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Adhere to standard precautions. (See  <a class="medical medical_review" href="/d/html/4042.html" rel="external">"Infection prevention: Precautions for preventing transmission of infection", section on 'Standard precautions'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Adhere to droplet precautions. (See <a class="local">'Droplet precautions'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Use caution when performing aerosol-generating procedures. (See <a class="local">'Aerosol-generating procedures'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Manage visitor access and movement within the facility. (See <a class="local">'Managing visitor access'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Monitor influenza activity. Health care settings should establish mechanisms and policies by which HCP are alerted promptly about increased influenza activity in the community or if an outbreak occurs within the facility and when collection of clinical specimens for influenza testing may help to inform public health efforts. (See  <a class="medical medical_review" href="/d/html/7007.html" rel="external">"Seasonal influenza vaccination in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Implement environmental infection control and engineering controls. A detailed discussion of these measures can be found on the <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.cdc.gov%2Fflu%2Fprofessionals%2Finfectioncontrol%2Fhealthcaresettings.htm&amp;token=CJC1KXZ9L2C9nRXIqeyY%2Ba%2FA29Mj1sP5WTPaH%2F2rMfDDj57%2Bhv8kZnEIftlG6vtwAaEhTr6m5kpaE4D%2BNSFPkjhyOs8Z9YwkNqqJKs0uRHo%3D&amp;TOPIC_ID=6999" target="_blank">CDC's website</a>.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Train and educate HCP, including those employed by outside employers, on preventing transmission of infectious agents, including influenza virus. Training should be updated periodically and documented. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Key aspects of influenza prevention that should be emphasized include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Influenza signs, symptoms, complications, and risk factors for complications. HCP should be made aware that, if they have conditions that place them at higher risk of complications, they should inform their health care provider immediately if they become ill with an influenza-like illness so they can receive early treatment if indicated.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The central role of administrative controls such as vaccination, respiratory hygiene and cough etiquette, sick policies, and precautions during aerosol-generating procedures.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Appropriate use of personal protective equipment including respirator fit testing and fit checks.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Use of engineering controls and work practices including infection control procedures to reduce exposure.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Administer antiviral treatment and chemoprophylaxis of patients and health care personnel when appropriate. (See  <a class="medical medical_review" href="/d/html/6998.html" rel="external">"Seasonal influenza in nonpregnant adults: Treatment"</a> and  <a class="medical medical_review" href="/d/html/7017.html" rel="external">"Seasonal influenza in adults: Role of antiviral prophylaxis for prevention"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Attend to the needs of health care personnel at higher risk for complications of influenza  (<a class="graphic graphic_table graphicRef72029" href="/d/graphic/72029.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/d/html/6998.html" rel="external">"Seasonal influenza in nonpregnant adults: Treatment"</a>.)</p><p></p><p class="headingAnchor" id="H8290432"><span class="h2">Immunization of health care personnel</span><span class="headingEndMark"> — </span>The care of patients with influenza has led to nosocomial transmission of disease, and infected health care personnel (HCP) have transmitted the virus to patients and other staff. Studies of immunization of HCP against seasonal influenza have demonstrated significant reductions in all-cause patient mortality and influenza-like illnesses among residents of long-term care facilities. (See  <a class="medical medical_review" href="/d/html/3889.html" rel="external">"Immunizations for health care providers", section on 'Influenza vaccine'</a>.)</p><p>The United States Centers for Disease Control and Prevention recommends that all HCP be vaccinated against seasonal influenza virus annually [<a href="#rid2">2</a>]. Strategies used by some institutions to improve vaccination rates among HCP have included providing incentives, providing vaccine at no cost to employees, improving access (eg, offering vaccination at work and during work hours), requiring HCP to sign declination forms to acknowledge that they have been educated about the benefits and risks of vaccination, and mandating influenza vaccination for all HCP without contraindications. Strong organizational leadership and an infrastructure for clear and timely communication and education and for program implementation have been elements of successful programs.</p><p>The Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America endorse a policy in which annual influenza vaccination is a condition of employment and/or professional privileges for HCP [<a href="#rid21">21,22</a>]. Some health care facilities that have required mandatory immunization of HCP have attained immunization rates greater than 97 percent [<a href="#rid23">23-25</a>].</p><p class="headingAnchor" id="H8292095"><span class="h2">General steps to minimize exposures</span><span class="headingEndMark"> — </span>A range of administrative policies and practices should be used to minimize influenza exposures in health care settings, particularly during periods of increased influenza activity [<a href="#rid2">2</a>]. These include:</p><p class="bulletIndent1"><span class="glyph">●</span>Screening and triage of symptomatic patients</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>When scheduling appointments, instructing patients to inform health care personnel upon arrival if they have symptoms of a respiratory infection and to take appropriate preventive actions (eg, wear a facemask upon entry, follow triage procedure)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>During periods of increased influenza activity, taking steps to minimize elective visits (eg, telemedicine appointments or telephone consultations for patients with mild respiratory illnesses who are not at increased risk for complications from influenza to determine if there is a medical need to visit the facility)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Implementation of respiratory hygiene, cough etiquette, and hand hygiene:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Posting visual alerts (eg, signs, posters) in strategic locations (eg, entrance, waiting areas, elevators, cafeterias) with instructions about respiratory hygiene, cough etiquette, and hand hygiene, especially when influenza virus is circulating in the community</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Implementing procedures during patient registration that facilitate adherence to appropriate precautions (eg, at the time of check-in, inquire about the presence of symptoms of respiratory infection and, if present, provide instructions)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Providing facemasks to patients with signs and/or symptoms of respiratory infection</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Providing alcohol-based hand sanitizers in strategic locations (eg, entrances, waiting rooms, and throughout facilities)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Providing space and encouraging patients with respiratory symptoms to physically distance from others as much as possible</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>During periods of increased influenza activity, setting up triage stations that facilitate rapid screening of patients for symptoms of influenza and separation from other patients</p><p></p><p>More details about these measures can be found on the United States <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.cdc.gov%2Fflu%2Fprofessionals%2Finfectioncontrol%2Fhealthcaresettings.htm&amp;token=CJC1KXZ9L2C9nRXIqeyY%2Ba%2FA29Mj1sP5WTPaH%2F2rMfDDj57%2Bhv8kZnEIftlG6vtwAaEhTr6m5kpaE4D%2BNSFPkjhyOs8Z9YwkNqqJKs0uRHo%3D&amp;TOPIC_ID=6999" target="_blank">Centers for Disease Control and Prevention's website</a>.</p><p class="headingAnchor" id="H7867242"><span class="h2">Isolation precautions</span><span class="headingEndMark"> — </span>Precautions to prevent the spread of influenza infections in health care facilities include the use of standard and droplet precautions for the routine care of patients infected with influenza virus.</p><p>Influenza viruses are thought to be spread via small particle aerosols and large droplets dispersed after coughing or sneezing [<a href="#rid2">2</a>]. Indirect contact from contaminated surfaces may also occur. (See  <a class="medical medical_review" href="/d/html/7004.html" rel="external">"Seasonal influenza in adults: Clinical manifestations and diagnosis", section on 'Transmission'</a>.)</p><p class="headingAnchor" id="H6"><span class="h3">Standard precautions</span><span class="headingEndMark"> — </span>Standard precautions should be used by all health care personnel (HCP) in the health care setting; standard precautions are the foundation for preventing transmission of infectious agents in health care settings [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/d/html/4042.html" rel="external">"Infection prevention: Precautions for preventing transmission of infection", section on 'Standard precautions'</a>.)</p><p class="headingAnchor" id="H8290607"><span class="h4">Hand hygiene</span><span class="headingEndMark"> — </span>Frequent hand hygiene should be performed, including before and after every patient contact, contact with potentially infectious material, and before putting on and after taking off personal protective equipment, including gloves [<a href="#rid2">2</a>]. Hand hygiene can be performed by washing with soap and water or by using alcohol-based hand rubs. If hands are visibly soiled, they should be washed with soap and water. Health care facilities should ensure that supplies for performing hand hygiene are readily available.</p><p>In a case-control study of HCP, assignment to units with &gt;75 percent adherence to hand hygiene practices was independently associated with protection from pandemic H1N1 influenza infection (adjusted odds ratio 0.45, 95% CI 0.27-0.89) [<a href="#rid26">26</a>].</p><p class="headingAnchor" id="H8290721"><span class="h4">Gloves</span><span class="headingEndMark"> — </span>Gloves should be used for any contact with potentially infectious material, followed by hand hygiene immediately after glove removal [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H8290708"><span class="h4">Gowns</span><span class="headingEndMark"> — </span>HCP should wear a gown for any patient care activity in which contact with blood, respiratory secretions, or other body fluids is anticipated [<a href="#rid2">2</a>]. The gown should be removed and hand hygiene should be performed before leaving the patient's environment.</p><p class="headingAnchor" id="H7"><span class="h3">Droplet precautions</span><span class="headingEndMark"> — </span>For the prevention of seasonal influenza transmission in health care settings, the United States Centers for Disease Control and Prevention (CDC) recommends the use of droplet precautions for the routine care of patients with suspected or confirmed influenza infection [<a href="#rid2">2</a>].</p><p>Droplet precautions include the following practices:</p><p class="bulletIndent1"><span class="glyph">●</span>Patients should be placed in a private room or area. When it is not possible to place a patient with influenza in a private room, consult with infection control personnel for input about other placement options (eg, grouping those with influenza together).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>HCP should wear a facemask when entering the patient's room. When leaving the patient's room, HCP should remove the facemask, dispose of it, and then perform hand hygiene. Some facilities may choose to provide HCP with alternative equipment, such as respirators and face shields. Studies that have compared facemasks to N95 respirators are discussed below. (See <a class="local">'Type of respiratory protection'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hospitalized patients should wear a facemask when they leave their room and should use respiratory hygiene, cough etiquette, and hand hygiene. Information about patients with suspected, probable, or confirmed influenza should be communicated to appropriate personnel before transferring them to other departments in the facility (eg, radiology) or to other facilities. A study of the use of facemasks versus N95 respirators in nine patients with seasonal influenza suggested that both types of mask are equally effective at filtering influenza virus [<a href="#rid27">27</a>].</p><p></p><p>Droplet precautions are discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/4042.html" rel="external">"Infection prevention: Precautions for preventing transmission of infection", section on 'Droplet precautions'</a>.)</p><p class="headingAnchor" id="H8291700"><span class="h4">Duration</span><span class="headingEndMark"> — </span>For immunocompetent inpatients with suspected or confirmed influenza infection, droplet precautions should generally be continued for seven days after illness onset or until 24 hours after resolution of fever and respiratory symptoms, whichever is longer [<a href="#rid2">2</a>].</p><p>Isolation precautions may be continued for a longer duration in patients who might shed influenza virus for a longer period, such as young children and severely immunocompromised individuals [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/d/html/7004.html" rel="external">"Seasonal influenza in adults: Clinical manifestations and diagnosis", section on 'Transmission'</a>.)</p><p>Patients should be discharged from the hospital based on their clinical status and should <strong>not</strong> be kept in the hospital based on the recommended duration of isolation.</p><p class="headingAnchor" id="H8291549"><span class="h3">Aerosol-generating procedures</span><span class="headingEndMark"> — </span>Aerosol-generating procedures include endotracheal intubation and extubation, bronchoscopy, sputum induction, cardiopulmonary resuscitation, open suctioning of airways, and autopsies [<a href="#rid2">2</a>]. During aerosol-generating procedures, each HCP should wear an N95 respirator (or an equivalent respirator such as a powered air purifying respirator) as well as adhere to standard precautions, including wearing gloves, a gown, and either a face shield that fully covers the front and sides of the face or goggles. Additional measures should be taken such as conducting procedures in an airborne infection isolation room when feasible and limiting the number of health care personnel present during the procedure. Portable high-efficiency particulate air (HEPA) filtration units can be used to decrease the concentration of contaminants in the air, but they do not eliminate the need for respiratory protection.</p><p>Aerosol-generating procedures should only be performed on patients with suspected or confirmed influenza when they are medically necessary and cannot be postponed [<a href="#rid2">2</a>]. Environmental surface cleaning should occur following these procedures.</p><p class="headingAnchor" id="H7867622"><span class="h3">Type of respiratory protection</span><span class="headingEndMark"> — </span>As discussed above, the CDC recommends facemasks for the routine care of patients with suspected or confirmed influenza infection and N95 respirators (or an equivalent respirator) for use during aerosol-generating procedures [<a href="#rid2">2</a>]. (See <a class="local">'Droplet precautions'</a> above and <a class="local">'Aerosol-generating procedures'</a> above.)</p><p>Both facemasks and N95 respirators decrease viral shedding into the environment and may also reduce hand-to-mouth inoculation of virus [<a href="#rid28">28</a>]. N95 respirators fit tightly and filter out small particles. However, the optimal use of N95 respirators requires fit testing, training, and medical clearance. Furthermore, it is not clear that N95 respirators are more efficacious than facemasks in preventing influenza [<a href="#rid29">29</a>].</p><p>During the 2009 to 2010 H1N1 influenza pandemic, the CDC and the Institute of Medicine recommended the use of fit-tested N95 respirators for health care personnel in close contact with patients with suspected or confirmed pandemic H1N1 influenza A infection [<a href="#rid30">30-32</a>]. However, some facilities experienced shortages of N95 respirators. Additionally, there was controversy about the optimal mode of respiratory protection.</p><p>The efficacy of facemask use was addressed in a trial involving 1437 young adults living in university residence halls in which significant reductions in influenza-like illness were observed among those randomly assigned to a facemask and hand hygiene group compared with those assigned to no intervention [<a href="#rid33">33</a>]. All participants, including those in the control group, were also instructed on the importance of handwashing.</p><p>Most but not all studies have not shown a difference in efficacy between facemasks and N95 respirators for preventing influenza infections or other respiratory virus infections among HCP [<a href="#rid29">29,34-36</a>]. A 2017 meta-analysis of randomized trials indicated a protective effect of facemasks and N95 respirators in HCP against clinical respiratory illness (risk ratio [RR] 0.59, 95% CI 0.46-0.77) and influenza-like illness (RR 0.34, 95% CI 0.14-0.82) [<a href="#rid35">35</a>]. Compared with facemasks, N95 respirators conferred greater protection against clinical respiratory illness (RR 0.47, 95% CI 0.36-0.62) and laboratory-confirmed bacterial infections (RR 0.46, 95% CI 0.34-0.62) but not against viral infections or influenza-like illness.</p><p>In a subsequent randomized trial that included 2371 HCP from 137 outpatient sites at seven United States medical centers, pairs of outpatient sites within each center were matched and randomly assigned to have their HCP use N95 respirators or facemasks when coming within 6 feet of patients with respiratory illness during the 12-week period of peak viral respiratory illness over four influenza seasons [<a href="#rid36">36</a>]. There were a similar number of laboratory-confirmed influenza infection events in the N95 respirator and facemask groups (207 versus 193 events; adjusted odds ratio 1.18, 95% CI 0.95-1.45). There were also no significant differences between the groups in the incidence of acute respiratory illness events, laboratory-detected respiratory infections, laboratory-confirmed respiratory illness events, or influenza-like illness events.</p><p>For respiratory protection to be effective, it is crucial to achieve a proper fit. In a study that used coughing and breathing manikins, a tightly sealed facemask blocked entry of 94.8 percent of infectious influenza virus from entering the mouth and a tightly sealed N95 respirator blocked 99.6 percent of infectious virus [<a href="#rid6">6</a>]. By contrast, a poorly fitting facemask blocked entry of 56.6 percent of infectious virus, and a poorly fitting N95 respirator blocked 66.5 percent of infectious virus.</p><p>The use of facemasks in the household setting is discussed separately. (See  <a class="medical medical_review" href="/d/html/6998.html" rel="external">"Seasonal influenza in nonpregnant adults: Treatment", section on 'Infection control and returning to work/school'</a>.)</p><p class="headingAnchor" id="H8292076"><span class="h2">Managing visitor access</span><span class="headingEndMark"> — </span>Visitor access to patients in isolation for influenza should generally be limited to individuals who are necessary for the patient's care and well-being [<a href="#rid2">2</a>]. When visits are planned, the following measures should be taken:</p><p class="bulletIndent1"><span class="glyph">●</span>Visitors should be screened for symptoms of acute respiratory illness before entering the facility.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Facilities should provide instruction before visitors enter the patient's room on hand hygiene, limiting surfaces touches, and use of personal protective equipment.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Visitors should use respiratory hygiene and cough etiquette.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Visitors should not be present for aerosol-generating procedures.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Visitors should be instructed to limit their movement within the facility.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Visitors should be vaccinated against influenza by their health care provider.</p><p></p><p>Health care facilities should develop visitor restriction policies for individuals with respiratory symptoms related to the location of the patient being visited (eg, oncology units). Specific circumstances requiring exemption from the restriction (eg, end-of-life situations) should also be considered. (See <a class="local">'General steps to minimize exposures'</a> above.)</p><p class="headingAnchor" id="H8292979"><span class="h2">Managing health care personnel</span></p><p class="headingAnchor" id="H8293042"><span class="h3">Chemoprophylaxis</span><span class="headingEndMark"> — </span>Recommendations for antiviral prophylaxis following exposure to individuals with influenza infection are reviewed separately. (See  <a class="medical medical_review" href="/d/html/7017.html" rel="external">"Seasonal influenza in adults: Role of antiviral prophylaxis for prevention"</a>.)</p><p class="headingAnchor" id="H8292229"><span class="h3">Ill health care personnel</span><span class="headingEndMark"> — </span>Health care personnel (HCP) with fever and respiratory symptoms should [<a href="#rid2">2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Not report to work or, if already at work, stop patient-care activities, wear a facemask, and promptly notify their supervisor and infection control or occupational health before swiftly leaving work.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Be reminded that adherence to respiratory hygiene, cough etiquette, and hand hygiene after returning to work is important.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If symptoms such as coughing and sneezing are still present, wear a facemask after returning to work.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Be excluded from work until at least 24 hours after fever has abated (without the use of antipyretics).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Be evaluated by occupational health before returning to work if respiratory symptoms remain present.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Be considered for temporary reassignment or exclusion from work for seven days after symptom onset or until resolution of symptoms, whichever is longer, if returning to care for patients in a protected environment, such as hematopoietic cell transplant recipients.</p><p></p><p>Fever may be absent [<a href="#rid37">37</a>]; therefore, it may be difficult to differentiate influenza from other causes of respiratory symptoms, especially early in the course of illness. HCP with isolated fever should leave work or stay home. </p><p>Additional recommendations for the evaluation and management of ill HCP and the development of sick leave policies can be found on the United States <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.cdc.gov%2Fflu%2Fprofessionals%2Finfectioncontrol%2Fhealthcaresettings.htm&amp;token=CJC1KXZ9L2C9nRXIqeyY%2Ba%2FA29Mj1sP5WTPaH%2F2rMfDDj57%2Bhv8kZnEIftlG6vtwAaEhTr6m5kpaE4D%2BNSFPkjhyOs8Z9YwkNqqJKs0uRHo%3D&amp;TOPIC_ID=6999" target="_blank">Centers for Disease Control and Prevention's website</a>.</p><p>The treatment of influenza is discussed separately. (See  <a class="medical medical_review" href="/d/html/6998.html" rel="external">"Seasonal influenza in nonpregnant adults: Treatment"</a>.)</p><p class="headingAnchor" id="H8292207"><span class="h3">HCP at increased risk for complications</span><span class="headingEndMark"> — </span>It is particularly important that health care personnel (HCP) who are at increased risk for influenza complications be vaccinated annually against influenza  (<a class="graphic graphic_table graphicRef72029" href="/d/graphic/72029.html" rel="external">table 1</a>); such individuals should also be treated early if influenza infection develops [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/d/html/6998.html" rel="external">"Seasonal influenza in nonpregnant adults: Treatment"</a>.)</p><p>Work accommodations to avoid potentially high-risk exposures to patients with suspected or confirmed influenza (eg, participation in aerosol-generating procedures) may be considered in some settings, such as HCP with severe underlying diseases [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/d/html/6998.html" rel="external">"Seasonal influenza in nonpregnant adults: Treatment"</a>.)</p><p class="headingAnchor" id="H425162455"><span class="h2">Monitoring influenza activity</span><span class="headingEndMark"> — </span>Health care facilities should implement mechanisms and policies by which health care personnel (HCP) are alerted promptly about increased influenza activity in the community or if an outbreak occurs within the facility and when collection of clinical specimens for influenza virus testing may help to inform public health efforts to control transmission [<a href="#rid2">2</a>]. Close communication and collaboration with local and state health authorities is recommended. Policies should include designation of specific persons within the health care facility who are responsible for communication with public health officials and dissemination of information to HCP.</p><p class="headingAnchor" id="H3890970753"><span class="h2">Antiviral treatment and prophylaxis</span><span class="headingEndMark"> — </span>Some studies have suggested that early antiviral treatment of influenza-infected persons reduces transmission via diminished shedding [<a href="#rid38">38</a>], although the magnitude of effect is uncertain [<a href="#rid38">38-40</a>]. Issues for related to antiviral prophylaxis for prevention of infection following exposure to individuals with influenza are reviewed separately. (See  <a class="medical medical_review" href="/d/html/7017.html" rel="external">"Seasonal influenza in adults: Role of antiviral prophylaxis for prevention"</a>.)</p><p class="headingAnchor" id="H4031817984"><span class="h1">INFECTION PREVENTION IN THE OUTPATIENT SETTING</span><span class="headingEndMark"> — </span>Home-based infection control measures home may be beneficial [<a href="#rid41">41,42</a>]. One cluster-randomized trial found that use of hand hygiene and face masks reduced household transmission when implemented within 36 hours of symptom onset in the index patient (adjusted odds ratio 0.33, 95% CI 0.13-0.87) [<a href="#rid41">41</a>].</p><p>Issues for related to antiviral prophylaxis for prevention of infection following exposure to individuals with influenza are reviewed separately. (See  <a class="medical medical_review" href="/d/html/7017.html" rel="external">"Seasonal influenza in adults: Role of antiviral prophylaxis for prevention"</a>.)</p><p class="headingAnchor" id="H3463520013"><span class="h1">RETURNING TO WORK/SCHOOL</span><span class="headingEndMark"> — </span>Individuals with influenza who are managed as outpatients should remain home from work, school, and other public places until at least 24 hours after defervescence (without use of antipyretics) [<a href="#rid43">43</a>].</p><p class="headingAnchor" id="H2461057170"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/115160.html" rel="external">"Society guideline links: Infection control"</a>.)</p><p class="headingAnchor" id="H26"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>In order to optimally prevent or control influenza outbreaks, it is important to identify cases early and implement multiple infection control measures as soon as possible. Recommendations regarding infection control measures for seasonal influenza infection in health care settings have been provided by the United States Centers for Disease Control and Prevention (CDC). (See <a class="local">'Introduction'</a> above and <a class="local">'Overview'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Influenza virus spreads primarily via person-to-person respiratory transmission, which occurs via close-range contact (ie, within approximately six feet) via large droplets (≥100 microns) and as well as aerosols (&lt;100 microns). The typical incubation period is one to four days (average two days). The time between onset of illness among household contacts (known as the serial interval) is three to four days. (See <a class="local">'Transmission'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>All health care personnel (HCP) should be vaccinated against seasonal influenza annually. The Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America endorse a policy in which annual influenza vaccination is a condition of employment and/or professional privileges for HCP. (See <a class="local">'Immunization of health care personnel'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>It is particularly important that HCP who are at increased risk for influenza complications be vaccinated annually against influenza  (<a class="graphic graphic_table graphicRef72029" href="/d/graphic/72029.html" rel="external">table 1</a>); such individuals should also be treated early if influenza infection develops. (See <a class="local">'HCP at increased risk for complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A range of administrative policies and practices should be used to minimize influenza exposures in health care settings, particularly during periods of increased influenza activity. (See <a class="local">'General steps to minimize exposures'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Precautions to prevent the spread of influenza infections in health care facilities include the use of standard and droplet precautions when caring for patients infected with influenza virus. Facemasks should be used for the routine care of patients with suspected or confirmed influenza infection. Some facilities may make N95 respirators (or equivalent) available for routine care of patients with influenza infection. Respirators should be worn during aerosol-generating procedures. (See <a class="local">'Isolation precautions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Visitor access to patients in isolation for influenza should generally be limited to individuals who are necessary for the patient's care and well-being. (See <a class="local">'Managing visitor access'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>HCP with fever and respiratory symptoms should not report to work or, if already at work, should stop patient care activities, wear a facemask, promptly notify their supervisor and infection control, and leave work. (See <a class="local">'Ill health care personnel'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Individuals with influenza should remain home from work, school, and other public places until at least 24 hours after defervescence (without use of antipyretics). (See <a class="local">'Returning to work/school'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Additional details about infection control measures to prevent influenza in health care settings can be found on the <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.cdc.gov%2Fflu%2Fprofessionals%2Finfectioncontrol%2Fhealthcaresettings.htm&amp;token=CJC1KXZ9L2C9nRXIqeyY%2Ba%2FA29Mj1sP5WTPaH%2F2rMfDDj57%2Bhv8kZnEIftlG6vtwAaEhTr6m5kpaE4D%2BNSFPkjhyOs8Z9YwkNqqJKs0uRHo%3D&amp;TOPIC_ID=6999" target="_blank">CDC's website</a>.</p><p></p><p class="headingAnchor" id="H897938158"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Anna R Thorner, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Uyeki TM. 2009 H1N1 virus transmission and outbreaks. N Engl J Med 2010; 362:2221.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Prevention Strategies for Seasonal Influenza in Healthcare Settings. https://www.cdc.gov/flu/professionals/infectioncontrol/healthcaresettings.htm (Accessed on October 25, 2021).</li><li><a class="nounderline abstract_t">Cowling BJ, Ip DK, Fang VJ, et al. Aerosol transmission is an important mode of influenza A virus spread. Nat Commun 2013; 4:1935.</a></li><li><a class="nounderline abstract_t">Tellier R. Aerosol transmission of influenza A virus: a review of new studies. J R Soc Interface 2009; 6 Suppl 6:S783.</a></li><li><a class="nounderline abstract_t">Brankston G, Gitterman L, Hirji Z, et al. Transmission of influenza A in human beings. Lancet Infect Dis 2007; 7:257.</a></li><li><a class="nounderline abstract_t">Noti JD, Lindsley WG, Blachere FM, et al. Detection of infectious influenza virus in cough aerosols generated in a simulated patient examination room. Clin Infect Dis 2012; 54:1569.</a></li><li><a class="nounderline abstract_t">Bischoff WE, Swett K, Leng I, Peters TR. Exposure to influenza virus aerosols during routine patient care. J Infect Dis 2013; 207:1037.</a></li><li><a class="nounderline abstract_t">Yan J, Grantham M, Pantelic J, et al. Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community. Proc Natl Acad Sci U S A 2018; 115:1081.</a></li><li><a class="nounderline abstract_t">Bischoff WE, Reid T, Russell GB, Peters TR. Transocular entry of seasonal influenza-attenuated virus aerosols and the efficacy of n95 respirators, surgical masks, and eye protection in humans. J Infect Dis 2011; 204:193.</a></li><li class="breakAll">United States Centers for Disease Control and Prevention. Interim guidance on the use of influenza antiviral agents during the 2010-2011 influenza season https://www.cdc.gov/flu/professionals/antivirals/index.htm (Accessed on December 28, 2010).</li><li><a class="nounderline abstract_t">Cox NJ, Subbarao K. Influenza. Lancet 1999; 354:1277.</a></li><li><a class="nounderline abstract_t">Cowling BJ, Chan KH, Fang VJ, et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 2010; 362:2175.</a></li><li><a class="nounderline abstract_t">Carrat F, Vergu E, Ferguson NM, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008; 167:775.</a></li><li><a class="nounderline abstract_t">Lau LL, Cowling BJ, Fang VJ, et al. Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis 2010; 201:1509.</a></li><li><a class="nounderline abstract_t">Ip DK, Lau LL, Chan KH, et al. The Dynamic Relationship Between Clinical Symptomatology and Viral Shedding in Naturally Acquired Seasonal and Pandemic Influenza Virus Infections. Clin Infect Dis 2016; 62:431.</a></li><li><a class="nounderline abstract_t">Ip DK, Lau LL, Leung NH, et al. Viral Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Influenza Virus Infections in the Community. Clin Infect Dis 2017; 64:736.</a></li><li><a class="nounderline abstract_t">Leekha S, Zitterkopf NL, Espy MJ, et al. Duration of influenza A virus shedding in hospitalized patients and implications for infection control. Infect Control Hosp Epidemiol 2007; 28:1071.</a></li><li><a class="nounderline abstract_t">Lee N, Chan PK, Hui DS, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009; 200:492.</a></li><li><a class="nounderline abstract_t">Maier HE, Lopez R, Sanchez N, et al. Obesity Increases the Duration of Influenza A Virus Shedding in Adults. J Infect Dis 2018; 218:1378.</a></li><li><a class="nounderline abstract_t">Memoli MJ, Athota R, Reed S, et al. The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts. Clin Infect Dis 2014; 58:214.</a></li><li><a class="nounderline abstract_t">Talbot TR, Babcock H, Caplan AL, et al. Revised SHEA position paper: influenza vaccination of healthcare personnel. Infect Control Hosp Epidemiol 2010; 31:987.</a></li><li class="breakAll">Infectious Diseases Society of America. IDSA policy on mandatory immunization of health care workers against seasonal and pandemic influenza. https://www.idsociety.org/globalassets/idsa/policy--advocacy/current_topics_and_issues/immunizations_and_vaccines/health_care_worker_immunization/statements/idsa-policy-on-mandatory-influenza-immunization-of-health-care-workers-pdf (Accessed on November 27, 2018).</li><li><a class="nounderline abstract_t">Rakita RM, Hagar BA, Crome P, Lammert JK. Mandatory influenza vaccination of healthcare workers: a 5-year study. Infect Control Hosp Epidemiol 2010; 31:881.</a></li><li><a class="nounderline abstract_t">Talbot TR, Schaffner W. On being the first: Virginia Mason Medical Center and mandatory influenza vaccination of healthcare workers. Infect Control Hosp Epidemiol 2010; 31:889.</a></li><li><a class="nounderline abstract_t">Blank C, Gemeinhart N, Dunagan WC, Babcock HM. Mandatory employee vaccination as a strategy for early and comprehensive health care personnel immunization coverage: Experience from 10 influenza seasons. Am J Infect Control 2020; 48:1133.</a></li><li><a class="nounderline abstract_t">Apisarnthanarak A, Mundy LM. Factors associated with health care-associated 2009 influenza a (H1N1) virus infection among Thai health care workers. Clin Infect Dis 2010; 51:368.</a></li><li><a class="nounderline abstract_t">Johnson DF, Druce JD, Birch C, Grayson ML. A quantitative assessment of the efficacy of surgical and N95 masks to filter influenza virus in patients with acute influenza infection. Clin Infect Dis 2009; 49:275.</a></li><li><a class="nounderline abstract_t">Daniels TL, Talbot TR. Unmasking the confusion of respiratory protection to prevent influenza-like illness in crowded community settings. J Infect Dis 2010; 201:483.</a></li><li><a class="nounderline abstract_t">Loeb M, Dafoe N, Mahony J, et al. Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. JAMA 2009; 302:1865.</a></li><li class="breakAll">United States Centers for Disease Control and Prevention. Interim guidance on infection control measures for 2009 h1n1 influenza in healthcare settings, including protection of healthcare personnel http://www.cdc.gov/h1n1flu/guidelines_infection_control.htm (Accessed on October 14, 2011).</li><li><a class="nounderline abstract_t">Shine KI, Rogers B, Goldfrank LR. Novel H1N1 influenza and respiratory protection for health care workers. N Engl J Med 2009; 361:1823.</a></li><li class="breakAll">The National Academics of Sciences, Engineering, and Medicine. Respiratory Protection for Healthcare Workers in the Workplace Against Novel H1N1 Influenza A: A Letter Report. https://www.nap.edu/read/12748/chapter/1 (Accessed on October 25, 2021).</li><li><a class="nounderline abstract_t">Aiello AE, Murray GF, Perez V, et al. Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial. J Infect Dis 2010; 201:491.</a></li><li><a class="nounderline abstract_t">MacIntyre CR, Wang Q, Cauchemez S, et al. A cluster randomized clinical trial comparing fit-tested and non-fit-tested N95 respirators to medical masks to prevent respiratory virus infection in health care workers. Influenza Other Respir Viruses 2011; 5:170.</a></li><li><a class="nounderline abstract_t">Offeddu V, Yung CF, Low MSF, Tam CC. Effectiveness of Masks and Respirators Against Respiratory Infections in Healthcare Workers: A Systematic Review and Meta-Analysis. Clin Infect Dis 2017; 65:1934.</a></li><li><a class="nounderline abstract_t">Radonovich LJ Jr, Simberkoff MS, Bessesen MT, et al. N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial. JAMA 2019; 322:824.</a></li><li><a class="nounderline abstract_t">Javaid W, Ehni J, Gonzalez-Reiche AS, et al. Real-Time Investigation of a Large Nosocomial Influenza A Outbreak Informed by Genomic Epidemiology. Clin Infect Dis 2021; 73:e4375.</a></li><li><a class="nounderline abstract_t">Miyazawa S, Takazono T, Hosogaya N, et al. Comparison of Intra-Familial Transmission of Influenza Virus From Index Patients Treated With Baloxavir Marboxil or Oseltamivir Using an Influenza Transmission Model and a Health Insurance Claims Database. Clin Infect Dis 2022; 75:927.</a></li><li><a class="nounderline abstract_t">Goldstein E, Cowling BJ, O'Hagan JJ, et al. Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009. BMC Infect Dis 2010; 10:211.</a></li><li><a class="nounderline abstract_t">Nishiura H, Oshitani H. Household transmission of influenza (H1N1-2009) in Japan: age-specificity and reduction of household transmission risk by zanamivir treatment. J Int Med Res 2011; 39:619.</a></li><li><a class="nounderline abstract_t">Cowling BJ, Chan KH, Fang VJ, et al. Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Ann Intern Med 2009; 151:437.</a></li><li><a class="nounderline abstract_t">Little P, Stuart B, Hobbs FD, et al. An internet-delivered handwashing intervention to modify influenza-like illness and respiratory infection transmission (PRIMIT): a primary care randomised trial. Lancet 2015; 386:1631.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Guidance for school administrators to help reduce the spread of seasonal influenza in K-12 schools. https://www.cdc.gov/flu/school/guidance.htm (Accessed on February 25, 2019).</li></ol></div><div id="topicVersionRevision">Topic 6999 Version 28.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20558374" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : 2009 H1N1 virus transmission and outbreaks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20558374" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : 2009 H1N1 virus transmission and outbreaks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23736803" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Aerosol transmission is an important mode of influenza A virus spread.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19773292" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Aerosol transmission of influenza A virus: a review of new studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17376383" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Transmission of influenza A in human beings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22460981" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Detection of infectious influenza virus in cough aerosols generated in a simulated patient examination room.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23372182" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Exposure to influenza virus aerosols during routine patient care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29348203" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21673029" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Transocular entry of seasonal influenza-attenuated virus aerosols and the efficacy of n95 respirators, surgical masks, and eye protection in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21673029" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Transocular entry of seasonal influenza-attenuated virus aerosols and the efficacy of n95 respirators, surgical masks, and eye protection in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10520648" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Influenza.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20558368" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Comparative epidemiology of pandemic and seasonal influenza A in households.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18230677" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Time lines of infection and disease in human influenza: a review of volunteer challenge studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20377412" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Viral shedding and clinical illness in naturally acquired influenza virus infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26518469" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The Dynamic Relationship Between Clinical Symptomatology and Viral Shedding in Naturally Acquired Seasonal and Pandemic Influenza Virus Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28011603" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Viral Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Influenza Virus Infections in the Community.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17932829" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Duration of influenza A virus shedding in hospitalized patients and implications for infection control.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19591575" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Viral loads and duration of viral shedding in adult patients hospitalized with influenza.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30085119" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Obesity Increases the Duration of Influenza A Virus Shedding in Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24186906" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20807037" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Revised SHEA position paper: influenza vaccination of healthcare personnel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20807037" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Revised SHEA position paper: influenza vaccination of healthcare personnel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20653445" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Mandatory influenza vaccination of healthcare workers: a 5-year study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20653446" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : On being the first: Virginia Mason Medical Center and mandatory influenza vaccination of healthcare workers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32238270" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Mandatory employee vaccination as a strategy for early and comprehensive health care personnel immunization coverage: Experience from 10 influenza seasons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20597683" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Factors associated with health care-associated 2009 influenza a (H1N1) virus infection among Thai health care workers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19522650" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : A quantitative assessment of the efficacy of surgical and N95 masks to filter influenza virus in patients with acute influenza infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20088689" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Unmasking the confusion of respiratory protection to prevent influenza-like illness in crowded community settings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19797474" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19797474" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19797278" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Novel H1N1 influenza and respiratory protection for health care workers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19797278" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Novel H1N1 influenza and respiratory protection for health care workers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20088690" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21477136" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : A cluster randomized clinical trial comparing fit-tested and non-fit-tested N95 respirators to medical masks to prevent respiratory virus infection in health care workers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29140516" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Effectiveness of Masks and Respirators Against Respiratory Infections in Healthcare Workers: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31479137" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33252647" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Real-Time Investigation of a Large Nosocomial Influenza A Outbreak Informed by Genomic Epidemiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35100617" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Comparison of Intra-Familial Transmission of Influenza Virus From Index Patients Treated With Baloxavir Marboxil or Oseltamivir Using an Influenza Transmission Model and a Health Insurance Claims Database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20642862" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21672367" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Household transmission of influenza (H1N1-2009) in Japan: age-specificity and reduction of household transmission risk by zanamivir treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19652172" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26256072" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : An internet-delivered handwashing intervention to modify influenza-like illness and respiratory infection transmission (PRIMIT): a primary care randomised trial.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
